Condition
Psoriasis Guttate
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Active Not Recruiting1
Unknown1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT04645355Phase 4Active Not RecruitingPrimary
Guselkumab Immunogenetics
NCT04950218Recruiting
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
NCT05144165Unknown
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
Showing all 3 trials